Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Use this AXSM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AXSM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AXSM SEC filings page. Lician reads the product cache first so this HTML stays unique to Axsome Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full AXSM income, balance, and cash tables.